Meet the Advisors
We are proud to have assembled our first group of world-class industry experts who are collaborating with us by providing their expertise and guidance to help make the Molecule mission a success.
Our advisors have added significant value to the project by helping to define our technology approach, connecting us with leading relevant industry groups and establishing collaborations with these groups. In the coming months, we also have exciting updates about our first signed partnerships agreements and the launch of our alpha product with a first select set of research projects.
Join our telegram to connect with our team and stay up to date with the latest project announcements.
Morten Scheibye-Knudsen
MD, PhD (Science and Clinical Research)
Morten is a physician-scientist with a focus on biogerontology. His laboratory at The University of Copenhagen tries to understand the cellular and organismal consequences of DNA damage with the aim of developing interventions. They have discovered that DNA damage leads to changes in certain metabolites and that replenishment of these molecules may alter the rate of aging in model organisms. The overall goal of the lab is to further understand the aging process and to develop interventions that may lead to healthier aging. The goal is pursued through a variety of ways including in silico analyses, in vitro biochemistry and molecular biology as well as in vivo work on mouse models.
http://scheibye-knudsen.com/
https://icmm.ku.dk/english/research-groups/scheibye-knudsen-group/
https://www.linkedin.com/in/morten-scheibye-knudsen-1b30335/
Amanda McPherson
Open Source Foundation Formation
Amanda is currently an advisor, board member, writer and college lecturer. Most recently, she was the Chief Marketing Officer of the Linux Foundation, a worldwide non-profit that advances and protects the Linux operating system and other open source software projects. As a founding executive of the Linux Foundation, she helped grow the business to a $50m a year entity with 150 employees and established the brand as one of the most trusted names in open source software. Amanda has been involved in many of the technology world’s most disruptive technologies, from launching Java in 1996 to driving open source strategy and marketing for Linux.
https://www.linkedin.com/in/amandamcpherson/
https://twitter.com/amcpherson
Andrew Updegrove
Legal (IP Policies and Open Source Consortia) Gesmer Updegrove LLP
Andrew Updegrove is a co-founder and partner of the Boston law firm of Gesmer Updegrove LLP. Since 1988 he has worked with over 180 consortia, accredited standards development organizations and open source foundations, most of which he helped form, assisting the largest technology companies in the world. He has testified before the United States Department of Justice, Federal Trade Commission and Congressional and state committees regarding consortia and standard-setting, and has filed pro bono “friend of the court” briefs with the Federal Circuit Court, Supreme Court, and Federal Trade Commission on leading standards litigation. In 2002, he launched ConsortiumInfo.org, the most extensive resource on the Internet dedicated to consortia and standard-setting, and Standards Today, a monthly e-Journal of news, ideas and analysis on standard-setting that now has thousands of subscribers. The Standards Blog was added to ConsortiumInfo.org in 2005. In 2004 he was asked to join the United States Standards Strategy revision committee, received the President’s Award for Journalism from the American National Standards Institute (ANSI) in 2005, and has served as a member of the Boards of Directors of ANSI, the Free Standards Group, the Linux Foundation and WorkCred, as well as on the Advisory Board of HL7. He is a graduate of Yale University and the Cornell University Law School.
https://www.gesmer.com/team/andrew-s-updegrove
https://twitter.com/Adversego
Jonathan J. Darrow
S.J.D., J.D., M.B.A., LL.M. Legal (Pharmaceutical Policy and IP)
Jonathan J. Darrow joined the faculty of Harvard Medical School and the Program on Regulation, Therapeutics, and Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital in 2016, following service as Senior Law Clerk to a judge on the United States Court of Appeals for the Federal Circuit, the court that decides all patent appeals involving pharmaceuticals, biologics, and medical devices. He holds degrees in biological sciences/genetics, law, and business from Cornell, Duke, and Boston College, respectively, as well as a research doctorate in pharmaceutical policy and intellectual property theory from Harvard, where he also completed the LL.M. program. He has been qualified as a patent attorney since 2002. After admission to the California bar, Dr. Darrow worked on pharmaceutical litigation matters at Wiley Rein & Fielding in Washington , DC, served on the business law faculties of several universities, and explored the relationship between innovation policy and global health during stints at the World Trade Organization, the World Health Organization, and the World Intellectual Property Organization. He is a co-author of three textbooks, including Cyberlaw: Management & Entrepreneurship (2015) and The Legal and Ethical Environment of Business (2014). His scholarship on health policy and intellectual property has appeared in the British Medical Journal, the New England Journal of Medicine; the Journal of Law, Medicine & Ethics; the Stanford Technology Law Review; the Yale Journal of Health Policy Law & Ethics, and the Harvard Journal of Law & Technology, among many others, and he has testified before a committee of the Massachusetts legislature on an emerging issue of law and technology.
https://www.linkedin.com/in/jonathan-darrow-95b5561/
Allison Randal
Board Member at Open Source Initiative and OpenStack Foundation
Over the past decade, Allison has been researching open source and technology innovation, partly through employment at multiple different companies who engage in open source, and partly through academic work towards completing a Master’s degree and soon starting a PhD. The heart of this research is looking into what makes companies successful at open source and also at technology innovation. She is currently a director of the Open Source Initiative and was its president between 2015 and 2017, taking over from and handing back to Simon Phipps. She also serves on the OpenStack Foundation board of directors.
https://www.linkedin.com/in/allisonrandal/
https://twitter.com/allisonrandal
If you are interested in finding out more about Molecule or signing on as a research partner or collaborator, please reach out to us directly via email on info@molecule.to or contact the team via the telegram channel.
